Ładuje się......
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
The introduction of interferon beta therapies more than 20 years ago marked a milestone in the treatment of relapsing‐remitting multiple sclerosis (RRMS) with a significant impact on the approach to modern multiple sclerosis (MS) care. Key learnings and perspectives from the early days of disease mo...
Zapisane w:
| Wydane w: | Brain Behav |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5474703/ https://ncbi.nlm.nih.gov/pubmed/28638705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.696 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|